U.S. markets closed
  • S&P 500

    4,232.60
    +30.98 (+0.74%)
     
  • Dow 30

    34,777.76
    +229.26 (+0.66%)
     
  • Nasdaq

    13,752.24
    +119.44 (+0.88%)
     
  • Russell 2000

    2,271.63
    +30.21 (+1.35%)
     
  • Crude Oil

    64.82
    -0.08 (-0.12%)
     
  • Gold

    1,832.00
    +0.70 (+0.04%)
     
  • Silver

    27.57
    +0.09 (+0.32%)
     
  • EUR/USD

    1.2168
    +0.0100 (+0.83%)
     
  • 10-Yr Bond

    1.5770
    +0.0160 (+1.02%)
     
  • GBP/USD

    1.3990
    +0.0098 (+0.70%)
     
  • USD/JPY

    108.5400
    -0.5450 (-0.50%)
     
  • BTC-USD

    57,925.20
    -1,132.76 (-1.92%)
     
  • CMC Crypto 200

    1,480.07
    +44.29 (+3.08%)
     
  • FTSE 100

    7,129.71
    +53.54 (+0.76%)
     
  • Nikkei 225

    29,357.82
    +26.42 (+0.09%)
     

Crispr Therapeutics Ag (CRSP) CBO & COO Lawrence Otto Klein Sold $12.8 million of Shares

GuruFocus.com
·1 min read

- By insider

CBO & COO of Crispr Therapeutics Ag (30-Year Financial, Insider Trades) Lawrence Otto Klein (insider trades) sold 100,000 shares of CRSP on 03/23/2021 at an average price of $128.05 a share. The total sale was $12.8 million.


CRISPR Therapeutics AG is a gene editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics. Crispr Therapeutics Ag has a market cap of $8.64 billion; its shares were traded at around $114.600000 with and P/S ratio of 10418.19.

Directors and Officers Recent Trades:

  • CBO & COO Lawrence Otto Klein sold 100,000 shares of CRSP stock on 03/23/2021 at the average price of $128.05. The price of the stock has decreased by 10.5% since.

  • Director Bradley J Phd Bolzon sold 30,374 shares of CRSP stock on 03/22/2021 at the average price of $132.37. The price of the stock has decreased by 13.42% since.

For the complete insider trading history of CRSP, click here

.This article first appeared on GuruFocus.